Oncology
🇪🇺 EMAEMA news and analysis for pharmaceutical BD, investment, and market access
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 1–12 of 94 articles
Quick answer
NovaPharmaNews Oncology hub for EMA covers 94 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Duty of care at oncology conferences spotlights planetary health research
Synthetic real-world data reshapes oncology trial decision-making
European Cancer Guidelines Add Delcath Liver Therapy for Eye Melanoma
Florian Lordick Elected ESMO President 2029–2030: What Pharma Teams Should Watch
Hayes Receives 2026 ESMO Breast Cancer Award: Key Insights
Insights from ESMO Asia: Nadia Harbeck on Oncology Advances
Circulating Biomarkers: Additional Evidence Supporting Their Clinical Use in Breast Cancer
Key Cancer Drugs to Watch at ESMO 2025: Investor and BD Insights
Florian Lordick Elected 2026 ESMO President: Implications for Global Oncology
DEFINITIVE Trial Milestone: 50% Recruitment Achieved
Medscape Education Leverages AI for Hematology at EHA 2026
ASCO26: AstraZeneca's Camizestrant Data Aims to Sway FDA Approval
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.